Overview

Single Ascending-Dose Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Healthy Postmenopausal Women

Status:
Terminated

Trial end date:
2010-10-01

Target enrollment:

Participant gender:

Summary

Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Healthy Postmenopausal Women.

Phase:

Phase 1

Details

Lead Sponsor:

Cephalon